-John T Reilly Researcher Activity Profile

Research Author Detailed Information 

John T Reilly Publication Rate By Year

John T Reilly has published 1 paper(s) in 2005, 11 paper(s) in 2007, 2 paper(s) in 2008, for a total of 14 research publications in total.

John T Jt Reilly Author Information

LAST NAME: reilly

FIRST NAME: John T

INITIALS: jt

AFFILIATION:

Papers

John T Reilly's Publication Record

1. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice. Year Published: 2007
Royal Hallamshire Hospital, Sheffield, UK. j.t.reilly@sheffield.ac.uk
2. Practical approach to treating essential thrombocythaemia: case studies. Year Published: 2007
Royal Hallamshire Hospital, Sheffield, UK. j.t.reilly@sheffield.ac.uk
3. Gene structure, expression profiling and mutation analysis of the tumour suppressor SHIP1 in Caucasian acute myeloid leukaemia. Year Published: 2007
4. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Year Published: 2007
Department of Haematology, Floor C, Tower Block, Belfast City Hospital, Lisburn Road, Belfast BT9 7AB, N. Ireland. melanie.percy@bll.n-i.nhs.uk.
5. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Year Published: 2007
Department of Haematology, Floor C, Tower Block, Belfast City Hospital, Northern Ireland, UK. melanie.percy@bll.n-i.nhs.uk
6. Gene structure, expression profiling and mutation analysis of the tumour suppressor SHIP1 in Caucasian acute myeloid leukaemia. Year Published: 2007
7. A fatal case of disseminated zygomycosis associated with the use of blood glucose self-monitoring equipment. Year Published: 2005
Department of Microbiology, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, UK. fay.hampson@sth.nhs.uk
8. Myeloproliferative disorders: a time of new definitions. Outflow from New Horizons in Haematology Meeting, 9-10 March 2007. Year Published: 2007
Experimental Hematology, Department of Research, University Hospital Basel, Basel, Switzerland.
9. Implications of the consensus definition of clinical resistance and intolerance to hydroxyurea for clinical practice. Year Published: 2007
Royal Hallamshire Hospital, Sheffield, UK. j.t.reilly@sheffield.ac.uk
10. Practical approach to treating essential thrombocythaemia: case studies. Year Published: 2007
Royal Hallamshire Hospital, Sheffield, UK. j.t.reilly@sheffield.ac.uk
11. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Year Published: 2008
12. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Year Published: 2007
Mayo Clinic, Rochester, MN 55905, USA. ayalew@mayo.edu
13. Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment. Year Published: 2008
14. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Year Published: 2007
Department of Haematology, Floor C, Tower Block, Belfast City Hospital, Northern Ireland, UK. melanie.percy@bll.n-i.nhs.uk